Daniel Bradbury, Director at CASTLE BIOSCIENCES INC (CSTL), sold 23,430 shares at $20.06 ($470K) on 2023-12-01, disclosed to the SEC on 2023-12-05.
Scheduled sale ($470k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.06 | 3,025 | $61K | 12.9% |
| 2 | $20.06 | 3,025 | $61K | 12.9% |
| 3 | $20.06 | 3,259 | $65K | 13.9% |
| 4 | $20.06 | 3,259 | $65K | 13.9% |
| 5 | $20.06 | 3,261 | $65K | 13.9% |
| 6 | $20.06 | 3,261 |
| $65K |
| 13.9% |
| 7 | $20.08 | 1,375 | $28K | 5.9% |
| 8 | $20.08 | 1,482 | $30K | 6.3% |
| 9 | $20.08 | 1,483 | $30K | 6.3% |
| Total | $20.06 avg | 23,430 | $470K | 100% |
| Filing → |
| CSTL | SELL | 2024-12-05 | $344K | — | Filing → |
| CSTL | SELL | 2024-11-05 | $318K | — | Filing → |
| CSTL | SELL | 2024-10-09 | $337K | — | Filing → |